A well organised effort to metastatic non-clear-cell renal cell carcinoma

被引：1

作者：

Russo, Paul ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Weill Cornell Sch Med, New York, NY 10065 USA

来源：

LANCET ONCOLOGY | 2019年 / 20卷 / 04期

关键词：

THERAPY;

D O I：

10.1016/S1470-2045(19)30036-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：472 / 473

页数：2

共 8 条

[1] Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study [J].

Chanza, Nieves Martinez ;

Xie, Wanling ;

Bilen, Mehrnet Asim ;

Dzimitrowicz, Hannah ;

Burkart, Jarred ;

Geynisman, Daniel M. ;

Balakrishnan, Archana ;

Bowman, I. Alex ;

Jain, Rohit ;

Stadler, Walter ;

Zakharia, Yousef ;

Narayan, Vivek ;

Beuselinck, Benoit ;

McKay, Rana R. ;

Tripathi, Abhishek ;

Pachynski, Russell ;

Hahn, Andrew W. ;

Hsu, JoAnn ;

Shah, Sumit A. ;

Lam, Elaine T. ;

Rose, Tracy L. ;

Mega, Anthony E. ;

Vogelzang, Nicholas ;

Harrison, Michael R. ;

Mortazavi, Amir ;

Plimack, Elizabeth R. ;

Vaishampayan, Ulka ;

Hammers, Hans ;

George, Saby ;

Haas, Naomi ;

Agarwal, Neeraj ;

Pal, Sumanta K. ;

Srinivas, Sandy ;

Carneiro, Benedito A. ;

Heng, Daniel Y. C. ;

Bosse, Dominick ;

Choueiri, Toni K. ;

Harshman, Lauren C. .

LANCET ONCOLOGY, 2019, 20 (04) :581-590

[2] Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma [J].

Choueiri, T. K. ;

Escudier, B. ;

Powles, T. ;

Mainwaring, P. N. ;

Rini, B. I. ;

Donskov, F. ;

Hammers, H. ;

Hutson, T. E. ;

Lee, J-L ;

Peltola, K. ;

Roth, B. J. ;

Bjarnason, G. A. ;

Geczi, L. ;

Keam, B. ;

Maroto, P. ;

Heng, D. Y. C. ;

Schmidinger, M. ;

Kantoff, P. W. ;

Borgman-Hagey, A. ;

Hessel, C. ;

Scheffold, C. ;

Schwab, G. M. ;

Tannir, N. M. ;

Motzer, R. J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (19) :1814-1823

[3] Systemic Therapy for Metastatic Renal-Cell Carcinoma [J].

Choueiri, Toni K. ;

Motzer, Robert J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (04) :354-366

[4] Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Database Consortium criteria [J].

Kroeger, Nils ;

Xie, Wanling ;

Lee, Jae-Lyn ;

Bjarnason, Georg A. ;

Knox, Jennifer J. ;

MacKenzie, Mary J. ;

Wood, Lori ;

Srinivas, Sandy ;

Vaishamayan, Ulka N. ;

Rha, Sun-Young ;

Pal, Sumanta K. ;

Yuasa, Takeshi ;

Donskov, Frede ;

Agarwal, Neeraj ;

Kollmannsberger, Christian K. ;

Tan, Min-Han ;

North, Scott A. ;

Rini, Brian I. ;

Choueiri, Toni K. ;

Heng, Daniel Y. C. .

CANCER, 2013, 119 (16) :2999-3006

[5]

Molina AM, 2010, AM J CLIN ONCOL-CANC, V185, P433

[6] Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma [J].

Molina, Ana M. ;

Feldman, Darren R. ;

Ginsberg, Michelle S. ;

Kroog, Glenn ;

Tickoo, Satish K. ;

Jia, Xiaoyu ;

Georges, Murielle ;

Patil, Sujata ;

Baum, Michael S. ;

Reuter, Victor E. ;

Motzer, Robert J. .

INVESTIGATIONAL NEW DRUGS, 2012, 30 (01) :335-340

[7] Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology [J].

Motzer, RJ ;

Bacik, J ;

Mariani, T ;

Russo, P ;

Mazumdar, M ;

Reuter, V .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (09) :2376-2381

[8] Renal Cell Carcinoma in the Era of Precision Medicine: From Molecular Pathology to Tissue-Based Biomarkers [J].

Signoretti, Sabina ;

Flaifel, Abdallah ;

Chen, Ying-Bei ;

Reuter, Victor E. .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (36) :3553-+

← 1 →